Search
Advanced Search

Exclusive drug supply: Darbepoetin alfa (ARANESP), Evolocumab (REPATHA), Etelcalcetide (PARSABIV) and Filgrastim (NEUPOGEN vial).

Contract Award

General Information
   Jun 4, 2025
   Spanish
   International procurement
   published: Jun 4, 2025

Original Text

TED 00355626-2025 - Result Help Print Share Share × Facebook X/Twitter LinkedIn Email Cancel .ted-toolbar { display: flex;}.ted-mini-toolbar { display: flex; margin-bottom: 22px; margin-left: auto;}.ted-help,.ted-download,.ted-print,.ted-social-share { background: none; border: none; padding: 0;}.ted-print { margin-left: 24px;}.ted-social-share { margin-left:...
Membership Plans

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact us

Contract award information
   AMGEN S.A.
   AMGEN S.A., бул. Христофор Колумб №.43, ESP, +359 878538759, a.dimitrova@foodcard.bg
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any updates, corrections, or complaints related to this notice, please contact the responsible purchaser directly.